Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
16,496,810
-
Share change
-
-633,150
-
Total reported value
-
$1,073,027,505
-
Put/Call ratio
-
100%
-
Price per share
-
$65.41
-
Number of holders
-
141
-
Value change
-
-$47,497,883
-
Number of buys
-
51
-
Number of sells
-
70
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2021
As of 31 Dec 2021 DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) had 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,496,810 shares of stock of the company.
Largest 10 holders included ROYAL BANK OF CANADA, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, SCHRODER INVESTMENT MANAGEMENT GROUP, STATE STREET CORP, AMERIPRISE FINANCIAL INC, DIMENSIONAL FUND ADVISORS LP, GOLDMAN SACHS GROUP INC, and Nuveen Asset Management, LLC.
This table shows 141 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.